Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
Frequently Asked Questions / Types of Cancer / Gastrointestinal Cancers / Gastric Cancer
Li Liu, MD
Last Modified: November 1, 2001
Dear OncoLink "Ask the Experts,"
My mother was diagnosed with positive H. pylori. I understand that there is a correlation with gastric cancer. Are there initial screening methods to detect the early stage of gastric cancer and how significant is this correlation?
Thanks!
Li Liu, MD, OncoLink Editorial Assistant, responds:
Dear A:
Thank you for your interest and question.
Since the discovery of Helicobacter pylori (H. pylori) in the 1980s, much has been learned about this gram-negative spiral bacterium and its associated disease states. H. pylori can cause chronic gastritis and atrophic gastritis, which are early steps in the cancer formation (carcinogenesis) sequence (Gastroenterology 1972 Oct;63(4):584-92). Several studies have reported a significant association between H. pylori infection and gastric cancer (Gastroenterology 1993 Oct;105(4):1098-103). A multinational EUROGAST study of 17 populations from 13 different countries found a sixfold increased risk of gastric cancer in H. pylori-infected populations compared with uninfected populations (Lancet 1993 May 29;341(8857):1359-62). A recent study showed that certain strains of H. pylori produce a protein, cytotoxin-associated gene A (CagA), are more virulent in nature and produce significant amounts of gastritis and epithelial injury. Patients with CagA-positive H pylori infection have a slightly higher risk of developing stomach cancer than those with CagA-negative strains (Cancer Res 1995 May 15;55(10):2111-5).
Despite the positive association between H. pylori infection and gastric cancer, the question remains whether treatment of H. pylori infection reduces the risk of gastric cancer. One prospective study found the usefulness of H. pylori eradication in reverting precancerous lesions to be questionable (Gastroenterology 1997 Jul;113(1):25-30). The follow-up of this study remains too short to make any definitive conclusions. At present, there is insufficient data to recommend screening asymptomatic patients for H. pylori to prevent gastric cancer. However, decisions to screen based on risk factors, such as race, diet, and family history, can be made on an individual basis.
In addition to gastric carcinoma, H. pylori infection is also strongly associated with gastric lymphoma. But, the vast majority of people who carry this bacterium in their stomachs never develop cancer.
In the United States, there are three procedures commonly used when people are at risk for gastric cancer or when signs and symptoms of this disease are present; upper endoscopy, barium upper gastrointestinal radiographs, and endoscopic ultrasound. You should discuss your concern with her doctors. It is important to evaluate other risk factors, such as dietary habit, tobacco and alcohol use, previous stomach surgery, pernicious anemia, and family history of cancer.
What every person should know about screening, learning about your disease and the importance of cllinical research. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

